StockWatch
·

Research Reports

Latest coverage
Yesterday
MANIPALHOSManipal Health Enterprises Ltd

Record Revenue Masks Greenfield Headwinds

greenfield-execution · capex-cycle · volume-growth

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
MANIPALHOSManipal Health Enterprises Ltd

Record revenue, margin sustains amid integration costs

volume growth · margin stability · Sahyadri ramp

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
MANGALAMMANGALAM DRUGS & ORGANICS LTD.

Mangalam Drugs re-discloses ₹15.57 Cr bank default — overdue is now a third of its market cap

bank loan default · cash credit · SEBI LODR Regulation 30

Research4 minPharma & Healthcare
KPLKwality Pharmaceuticals Ltd

Strong Quarter, Concentrated Growth, Unproven Multiyear Roadmap

bioequivalence · MENA expansion · hormone plant

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
KPLKwality Pharmaceuticals Ltd

Strong delivery, bold ₹1,500 Cr FY30 vision with concrete milestones

bioequivalence pipeline · MENA expansion · hormone commercialization

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
Sat, 14 Nov
JSLLJeena Sikho Lifecare Ltd

Jeena Sikho Q2 FY27: PAT falls 38% YoY on margin compression despite 24% revenue growth

ayurveda · margin compression · healthcare expansion

ResultsQ2 FY273 minPharma & Healthcare
PANACEABIOPANACEA BIOTEC LTD.

Panacea Biotec swings to ₹11.9 Cr consolidated PAT in Q2 FY27, reversing year-ago loss

vaccines · profit turnaround · margin expansion

ResultsQ2 FY273 minPharma & Healthcare
GUFICBIOGUFIC BIOSCIENCES LTD.

Gufic Q2: consolidated PAT +40% YoY to ₹23.5 Cr, revenue +22%, but misses ₹35-42 Cr bar

pharmaceuticals · margin compression · topline growth

ResultsQ2 FY273 minPharma & Healthcare
HSILHemant Surgical Industries Ltd

Hemant Surgical H1 FY27: revenue +328% YoY to ₹276 Cr, PAT +245% amid margin compression

medical devices · government order · revenue growth

ResultsQ2 FY273 minPharma & Healthcare
ASTONEALABAstonea Labs Ltd

Astonea Labs H1FY27: consol PAT +149% YoY to ₹4.74 Cr, margins expand, revenue +45%

pharmaceuticals · cosmetics manufacturing · margin expansion

ResultsQ2 FY273 minPharma & Healthcare
HEALTHXSastasundar Ventures Ltd

Health X Platform Q2: loss narrows 18% YoY to ₹12.7 Cr, swings from Q1 profit on MTM hit

healthcare e-commerce distribution · retailershakti run rate · investment mark-to-market loss

ResultsQ2 FY273 minPharma & Healthcare
GPTHEALTHGPT Healthcare Ltd

Strong organic growth shadowed by Raipur losses and a missed breakeven

hospital · occupancy · Raipur

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
GPTHEALTHGPT Healthcare Ltd

Strong organic growth masked by Raipur losses, breakeven delayed

occupancy expansion · specialty services · Raipur losses

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
DCALDishman Carbogen Amcis Ltd

Dishman Carbogen Amcis swings to ₹66.7 Cr consolidated loss, revenue down 22% YoY

cdmo · margin compression · net loss

ResultsQ2 FY273 minPharma & Healthcare
Fri, 13 Nov
ASTERDMAster DM Healthcare Ltd

Margins Hit 5 Quarters Early, But Street Is Exiting — Here's Why

margin acceleration · synergy delivery · greenfield ramp

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
ASTERDMAster DM Healthcare Ltd

Margins hit 24% target early; synergies front-loading ahead of schedule

synergy acceleration · margin expansion · capacity addition

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
INNOVACAPInnova Captab Ltd

Innova Captab: Consol PAT +43% YoY, margin expands YoY but cools to 14.1% QoQ

pharma cdmo · branded generics · margin compression

ResultsQ2 FY273 minPharma & Healthcare
ASARFIAsarfi Hospital Ltd

Asarfi Hospital Q2 FY27: Consol PAT Up 45% YoY to ₹6.09 Cr, EBITDA Margin Hits 23.4%

hospital services · margin expansion · ebitda margin guidance

ResultsQ2 FY273 minPharma & Healthcare
VIYASHSEQUENT SCIENTIFIC LTD.

Viyash Q2 FY27: Consolidated PAT ₹84.7 Cr, ~16% Like-for-Like Growth as Margins Compress

animal health api · scheme of amalgamation · margin compression

ResultsQ2 FY273 minPharma & Healthcare
SYNCOMFSYNCOM FORMULATIONS (INDIA) LTD.-$

Syncom Formulations: consolidated PAT up 60.6% YoY on margin expansion, revenue +16.8%

pharmaceuticals formulations · margin expansion · consolidated vs standalone

ResultsQ2 FY273 minPharma & Healthcare
MEDICAMEQMEDICAMEN BIOTECH LTD.-$

Medicamen Biotech Q2 FY27: consolidated PAT surges 95% YoY on sharp margin expansion

pharmaceuticals · margin expansion · consolidated results

ResultsQ2 FY273 minPharma & Healthcare
MANIPALHOSManipal Health Enterprises Ltd

Manipal Health Q2 FY27: PAT falls 10% YoY on IPO charge; adjusted up ~22%

hospitals · ipo proceeds · margin compression

ResultsQ2 FY273 minPharma & Healthcare
SUPRIYASupriya Lifescience Ltd

₹1,000 Crore target now in structural jeopardy — margin collapse unforecasted

margin collapse · LATAM regulatory · Ambernath ramp

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
SUPRIYASupriya Lifescience Ltd

Margin collapse unforecasted; ₹1,000 Cr FY27 target now structurally at risk

LATAM regulatory shock · Ambernath ramp-up · margin compression

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
MARKSANSMARKSANS PHARMA LTD.

Record growth, margin resilience tested

geographic diversification · Europe acceleration · margin pressure

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
MARKSANSMARKSANS PHARMA LTD.

Record growth beats guidance, but QoQ PAT decline flags cost pressure

geographic diversification · Europe acceleration · capacity expansion

TranscriptDeep diveQ2 FY276 minPharma & Healthcare
NATCOPHARMNATCO PHARMA LTD.

Natco Q2 FY27: PAT down 61% YoY to ₹203 Cr (consolidated) as Lenalidomide fades

pharmaceuticals · lenalidomide · margin compression

ResultsQ2 FY273 minPharma & Healthcare
KMCSHILKMC SPECIALITY HOSPITALS (INDIA) LTD.

KMC Speciality: standalone PAT up 49.6% YoY to ₹16.2 Cr on margin gains, QoQ growth cools

healthcare · hospitals · margin expansion

ResultsQ2 FY273 minPharma & Healthcare
DIVISLABDIVI'S LABORATORIES LTD.

The Validation Batch Hangover: 35% Growth, 10% Base Business

validation batches · capex projects · peptides

Result verdictFollow-upQ2 FY276 minPharma & Healthcare
DIVISLABDIVI'S LABORATORIES LTD.

Strong growth, validation batches mask base business headwinds

validation batches · capex projects · peptides

TranscriptDeep diveQ2 FY276 minPharma & Healthcare